作者
Xuyu Qian,Ellen M. DeGennaro,Maya Talukdar,Shyam K. Akula,Abbe Lai,Diane D. Shao,Dilenny M. Gonzalez,Jack H. Marciano,Richard S. Smith,Norma K. Hylton,Edward Yang,J. Fernando Bazán,Lee C. Barrett,Rebecca C. Yeh,Robert Hill,Samantha G. Beck,Aoi Otani,Angad Jolly,Tadahiro Mitani,Jennifer E. Posey,Davut Pehli̇van,Daniel G. Calame,Hatip Aydın,Osman Yeşilbaş,Kendall C. Parks,Emanuela Argilli,Eleina England,Kiho Im,Ajay Taranath,Hamish S. Scott,Christopher Barnett,Peer Arts,Elliott H. Sherr,James R. Lupski,Christopher A. Walsh
摘要
Kinesins are canonical molecular motors but can also function as modulators of intracellular signaling. KIF26A, an unconventional kinesin that lacks motor activity, inhibits growth-factor-receptor-bound protein 2 (GRB2)- and focal adhesion kinase (FAK)-dependent signal transduction, but its functions in the brain have not been characterized. We report a patient cohort with biallelic loss-of-function variants in KIF26A, exhibiting a spectrum of congenital brain malformations. In the developing brain, KIF26A is preferentially expressed during early- and mid-gestation in excitatory neurons. Combining mice and human iPSC-derived organoid models, we discovered that loss of KIF26A causes excitatory neuron-specific defects in radial migration, localization, dendritic and axonal growth, and apoptosis, offering a convincing explanation of the disease etiology in patients. Single-cell RNA sequencing in KIF26A knockout organoids revealed transcriptional changes in MAPK, MYC, and E2F pathways. Our findings illustrate the pathogenesis of KIF26A loss-of-function variants and identify the surprising versatility of this non-motor kinesin.